Answers · Patent Costs & Budgeting
Are patents worth the cost for a startup?
Updated June 2026
The short answer
For most startups with genuinely novel technology, yes, selectively: one or two strong patent families usually justify their cost, and a blanket filing program usually does not. The unit of decision is commonly cited at $15,000 to $30,000 or more per US patent through grant, weighed against published research that has repeatedly associated early patents with higher fundraising success and stronger exit outcomes.
The question to actually answer is narrower than the headline: which one or two of your inventions would a competitor most want to copy and an acquirer most want to own? Those are worth patenting almost regardless of budget. The rest, at this stage, usually are not.
What the evidence says
Published studies of startup outcomes have repeatedly found that companies holding patents raise venture capital at higher rates and exit at higher values than comparable companies without them, and investor diligence checklists treat IP position as standard. The mechanism is mundane rather than magical: a filed patent is hard evidence that the technology is specific, novel enough to claim, and owned by the company rather than by a former employer.
None of that research proves a patent causes success, and it is fair to read some of it as strong companies patenting more. It is still the evidence the investor across the table has read.
The honest case against, and where it holds
The skeptic's argument is familiar from every founder forum: startups cannot afford multi-million dollar enforcement, software moves faster than examination, and the money is better spent shipping. Each point holds somewhere. If your advantage is execution speed, network effects, or proprietary data, and copying you would take a competitor years regardless, the patent budget may genuinely be better spent elsewhere, and trade secrets may fit better than filings. If the product will pivot twice before grant, early broad filing buys protection for something you will never sell.
The enforcement point is the weakest of the three, because it imagines litigation as the only way a patent pays. Acquirers price patents in diligence, investors price them in rounds, competitors route around credible claims, and contingency counsel and litigation finance exist for the strong cases. A startup's patent does most of its work without ever being asserted.
Selective filing in practice
The startups that get this right run the same play: identify the one or two inventions that make the company fundable and hard to copy, document them thoroughly, file provisionals early to lock priority dates ahead of pitching and publishing, and put real money into claim drafting on those few, in the three to five countries that matter. Everything else waits, or stays a trade secret.
That selection question, what is worth filing and what is not, is the work ipCapital Group does. We are a consultancy, not a law firm, and we do not bill attorney or government fees. We help startups decide and document, so the legal budget lands on filings the business will actually use.
Related questions
Are patents worth it for a software startup specifically?
Sometimes. Pure business-method ideas face well-known eligibility hurdles, but systems-level software inventions (infrastructure, ML pipelines, processing architectures) are patented successfully every day. Eligibility is a question for patent counsel per invention; whether the filing is worth it still turns on whether the invention carries the company's value.
Should we patent it or keep it a trade secret?
Patent what others could observe, reverse engineer, or independently file on; keep secret what they cannot. Many strong startup IP positions are a small set of patents over a base of well-managed trade secrets.
What if we only have $10,000?
A professionally drafted provisional on your single most important invention preserves the decision for a year at a fraction of full filing cost. Spreading the same money across three thin do-it-yourself filings is the common mistake.
Do investors really walk away over IP?
More often they reprice or restructure: a weak IP position shows up in valuation and in diligence conditions. Clean chain of title (every founder and contractor assignment signed) kills more deals than missing patents do.
Decide what is worth filing
Bring the two or three inventions you are debating. A free discovery call is usually enough to see which ones carry the company's value, and a selection engagement is a fixed-scope project.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.